Merck MRK
NYSE MRK
$147.53 -0.93 (-0.63%)
As of: Sep 9, 2026 · 3:59 PM EDT

Merck (MRK) Total Liabilities (2009 - 2026)

Merck's (MRK) quarterly Total Liabilities came in at $23.7 billion in Q2 2026, down 65.33% year-over-year from $68.5 billion in Q2 2025, and down 71.32% quarter-over-quarter from $82.8 billion in Q1 2026.

Analysis

Merck (MRK) Total Liabilities (2009 - 2026) Analysis & Trends

Merck (MRK) has reported Total Liabilities for 18 consecutive years, with $23.7 billion the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Total Liabilities fell 65.33% year-over-year to $23.7 billion in Q2 2026; TTM through Jun 2026 was $23.7 billion, a 65.33% decrease from a year earlier, with the FY2025 full-year figure at $21.3 billion, up 21161.0% from the prior year.
  • Total Liabilities was $23.7 billion for Q2 2026 at Merck, down from $82.8 billion in the prior quarter.
  • Over five years, Total Liabilities peaked at $82.8 billion in Q1 2026 and troughed at $100.0 million in Q4 2024.
  • A 5-year average of $34.2 billion and a median of $22.5 billion in 2025 frame the typical range for Total Liabilities.
  • Across the five-year window, Total Liabilities plunged 99.6% in 2023 and jumped 53277.6% in 2025, its largest moves.
  • Over 5 years, Total Liabilities stood at $600.0 million in 2022, then tumbled by 58.33% to $250.0 million in 2023, then slumped by 60.0% to $100.0 million in 2024, then soared by 21161.0% to $21.3 billion in 2025, then climbed by 11.65% to $23.7 billion in 2026.
  • The last three Total Liabilities figures came in at $23.7 billion (Q2 2026), $82.8 billion (Q1 2026), and $21.3 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 116.09 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn 141.05 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn 23.74 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn 80.09 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn 115.64 Bn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn 69.15 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn - 1.72 Bn
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 1.53 Bn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 819.80 Mn
10 Neurocrine Biosciences 15.65 Bn 15.26 Bn 935.80 Mn 1.67 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.74 Bn
Mar 31, 2026 82.75 Bn
Dec 31, 2025 21.26 Bn
Sep 30, 2025 15.90 Bn
Jun 30, 2025 68.46 Bn
Mar 31, 2025 66.72 Bn
Dec 31, 2024 100.00 Mn
Sep 30, 2024 72.97 Bn
Jun 30, 2024 68.98 Bn
Mar 31, 2024 125.00 Mn
Dec 31, 2023 250.00 Mn
Sep 30, 2023 250.00 Mn
Jun 30, 2023 65.73 Bn
Mar 31, 2023 125.00 Mn
Dec 31, 2022 600.00 Mn
Sep 30, 2022 62.56 Bn
Jun 30, 2022 63.78 Bn
Mar 31, 2022 600.00 Mn
Dec 31, 2021 400.00 Mn
Sep 30, 2021 57.63 Bn